Taipei Veterans General Hospital, founded in 1958, is one of Taiwan's three great medical centres; it opened Taiwan's first carbon-ion therapy centre in 2023, enrols heavily into EGFR and immunotherapy lung cancer trials, and runs Taiwan Cooperative Oncology Group studies.
Taipei Veterans General Hospital, founded in 1958, is a national medical centre affiliated to National Yang Ming Chiao Tung University and one of Taiwan's most active clinical research sites. Its oncology strengths include thoracic oncology (a leading enroller in EGFR and immunotherapy trials), hepatocellular carcinoma and portal hypertension research, gastric and colorectal surgery, and paediatric oncology. The hospital opened Taiwan's first heavy ion (carbon-ion) therapy centre in 2023 and runs a large cancer immunotherapy and cell therapy programme under Taiwan's special-access regulations. TVGH also hosts extensive registry-based research and Taiwan Cooperative Oncology Group trials.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Taipei Veterans General Hospital, including child institutions. 440 works · 3,370 citations · 77% open access · 10% clinical trials · 1% reviews.
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy.
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy, Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS).
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy, Hepatocellular carcinoma.
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy.
Shares Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer.
Shares Hitachi (particle therapy), CAR-T cell therapy, Hepatocellular carcinoma, Colorectal cancer.
Shares Hitachi (particle therapy), Hepatocellular carcinoma, Non-small-cell lung cancer.
Shares Carbon-ion synchrotrons and facilities, Carbon-ion therapy, Hepatocellular carcinoma.